News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,859 Results
Type
Article (88869)
Company Profile (816)
Press Release (795152)
Multimedia
Podcasts (242)
Webinars (35)
Section
Business (233634)
Career Advice (4164)
Deals (40009)
Drug Delivery (180)
Drug Development (91751)
Employer Resources (207)
FDA (18575)
Job Trends (17492)
News (398822)
Policy (40020)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (242)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (573)
Approvals (18945)
Artificial intelligence (897)
ASCO (345)
Autoimmune disease (372)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (73)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (482)
Bladder cancer (214)
Brain cancer (86)
Breast cancer (852)
Cancer (6701)
Cardiovascular disease (565)
Career advice (3600)
Career pathing (52)
CAR-T (390)
CDC (77)
Celiac Disease (3)
Cell therapy (1091)
Cervical cancer (58)
Clinical research (79221)
Collaboration (2422)
Commercialization (1)
Company closure (8)
Compensation (1543)
Complete response letters (107)
COVID-19 (3044)
CRISPR (127)
C-suite (1318)
Cystic fibrosis (168)
Data (8849)
Decentralized trials (3)
Denatured (93)
Depression (199)
Dermatology (99)
Diabetes (717)
Diagnostics (7623)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (451)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (323)
Earnings (102514)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138866)
Executive appointments (1207)
FDA (22741)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1995)
Gene editing (276)
Generative AI (91)
Gene therapy (862)
GLP-1 (1293)
Government (5569)
Grass and pollen (8)
Guidances (423)
Healthcare (21270)
Hematology (198)
HIV (99)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (217)
Infectious disease (3452)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (328)
Interviews (822)
IPO (18008)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (693)
Leadership (54)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (884)
Lymphoma (483)
Machine learning (70)
Management (67)
Manufacturing (1267)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15296)
Medtech (15473)
Mergers & acquisitions (23323)
Metabolic disorders (1853)
mRNA (275)
Multiple sclerosis (210)
NASH (24)
Neurodegenerative disease (522)
Neuropsychiatric disorders (131)
Neuroscience (3773)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (83)
Obesity (882)
Opinion (377)
Ovarian cancer (247)
Pain (288)
Pancreatic cancer (370)
Parkinson's disease (424)
Partnered (41)
Patents (668)
Patient recruitment (792)
Peanut (71)
People (68104)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24482)
Phase 2 (34422)
Phase 3 (25872)
Pipeline (10047)
Policy (404)
Postmarket research (3560)
Preclinical (10996)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (376)
Rare diseases (1299)
Real estate (7462)
Recruiting (81)
Regulatory (30530)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (45)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (342)
Series B (250)
Service/supplier (28)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4375)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (146)
Vaccines (1318)
Venture capital (141)
Weight loss (601)
Women's health (146)
Worklife (25)
Date
Today (74)
Last 7 days (442)
Last 30 days (2795)
Last 365 days (33076)
2026 (17222)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52377)
Australia (9206)
California (14560)
Canada (4065)
China (1616)
Colorado (625)
Connecticut (648)
Delaware (451)
Europe (120768)
Florida (2175)
Georgia (473)
Hawaii (4)
Idaho (70)
Illinois (1272)
India (105)
Indiana (674)
Iowa (26)
Japan (614)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1756)
Massachusetts (10668)
Michigan (427)
Minnesota (813)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3860)
New Mexico (35)
New York (3839)
North Carolina (1953)
North Dakota (11)
Northern California (7246)
Ohio (456)
Oklahoma (27)
Oregon (55)
Pennsylvania (2858)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5722)
Tennessee (235)
Texas (2382)
United States (52110)
Utah (434)
Vermont (2)
Virginia (376)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 884,859 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuropsychiatric disorders
Otsuka’s drug eases symptom burden, anxiety in ADHD as FDA verdict nears
The positive ADHD data for Otsuka Pharmaceutical’s centanafadine is good news in what has of late been a mixed bag for the neuropsychiatric space.
June 26, 2026
·
2 min read
·
Tristan Manalac
Pipeline
Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms
Jefferies expects Moderna to have around seven commercial products in the coming years which, along with a projected 10% revenue growth, could help the company break even in 2028.
June 26, 2026
·
2 min read
·
Tristan Manalac
M&A
Merck KgaA inks $11B Bio-Techne buyout to expand into cell therapy production
The company is “especially excited” about an immune cell therapy manufacturing technology included in the deal, a Merck KGaA executive said.
June 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Elixirgen Therapeutics and Nippon Shinyaku Enter into an Option Agreement for the Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
June 26, 2026
·
2 min read
Press Releases
MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease
June 26, 2026
·
6 min read
Press Releases
Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC
June 26, 2026
·
5 min read
Press Releases
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
June 26, 2026
·
3 min read
Press Releases
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
June 26, 2026
·
10 min read
Press Releases
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
June 25, 2026
·
5 min read
Press Releases
Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors
June 25, 2026
·
4 min read
1 of 88,486
Next
